Translational Research Cancer Center Consortium Inc

The TRCCC is composed of Cancer Centers, or Academic Institutions with a major focus on cancer research, within an easily accessible distance to the yearly meeting site that advances the dissemination of research and new clinical trials towards the prevention, treatment and cure of cancer, with an emphasis on the study of Immuno-Oncology, immunotherapy and other biological therapies of cancer. Each member institution may choose up to two faculty members to provide their current research in platform presentations, and to have their trainees present short talks and/or posters, at the yearly meeting. Each member institution also can have their Center participate in any clinical trials that are developed at TRC3 centers and other types of inter-institutional scientific collaborations and training opportunities, such as joint NIH training grants, NCI SPORES and P01s.